Bernard D P, Waksman B H
Ann Immunol (Paris). 1975 Feb-Mar;126(2):121-35.
Potentiation by cytochalasin B (CB) of (3H)thymidine incorporation in lymphoid cell suspensions stimulated by phytohemagglutinin (PHA) is counteracted by adherent cells. The drug has no effect on the production of the macrophage product lymphocyte activating factor (LAF) and does not interfere with its potentiating activity. CB appears to inhibit agglutination of lymphocytes. Other factors (absence of serum, macrophages, mechanical disturbance of the cultures) diminishing the size of aggregates increase the response of lymphocytes. Responses to less agglutinating mitogens are less or not enhanced by CB. Factors increasing agglutination or/and cell contacts (high cell density, wheat germ agglutinin) diminish lymphocyte activation and make it susceptible to CB potentiating effect. The results suggest that topoinhibition (cell contact inhibition) is an important mechanism regulating the lymphocyte response to mitogens in culture. Its effect could be modulated by macrophages and certain serum factors, and CB would potentiate these responses by reducing contact inhibition.
细胞松弛素B(CB)对植物血凝素(PHA)刺激的淋巴细胞悬液中(3H)胸腺嘧啶核苷掺入的增强作用会被贴壁细胞抵消。该药物对巨噬细胞产物淋巴细胞激活因子(LAF)的产生没有影响,也不干扰其增强活性。CB似乎能抑制淋巴细胞的凝集。其他降低聚集体大小的因素(无血清、巨噬细胞、培养物的机械干扰)会增加淋巴细胞的反应。对凝集性较弱的有丝分裂原的反应,CB增强作用较小或无增强作用。增加凝集或/和细胞接触的因素(高细胞密度、麦胚凝集素)会降低淋巴细胞的活化,并使其易受CB增强作用的影响。结果表明,拓扑抑制(细胞接触抑制)是调节培养中淋巴细胞对有丝分裂原反应的重要机制。其作用可能受到巨噬细胞和某些血清因子的调节,而CB会通过减少接触抑制来增强这些反应。